Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Net Asset Quality Index
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. net asset quality index. Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) has a Net Asset Quality Index of 65.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.80 Billion minus total liabilities of CN¥1.30 Billion yields net assets of CN¥2.50 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of Hangzhou Bio-Sincerity Pharma-Tech Co.Lt for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (2019–2025)
Net asset quality index of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. from 2019 to 2025. This chart shows how Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.'s Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the index stands at 65.8%, representing net assets of CN¥2.50 Billion against total assets of CN¥3.80 Billion CNY. Check tangible equity quality of Hangzhou Bio-Sincerity Pharma-Tech Co.Lt to evaluate the tangible quality of the company's equity base.
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Net Asset Quality Index by Year (2019–2025)
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. net asset quality index by year from 2019 to 2025. The table below presents the year-by-year Net Asset Quality Index for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 301096 market cap.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 67.5% | CN¥2.49 Billion | CN¥3.69 Billion | CN¥1.20 Billion | ▼ -1.8 pp |
| 2024 | 69.3% | CN¥2.58 Billion | CN¥3.72 Billion | CN¥1.14 Billion | ▼ -3.8 pp |
| 2023 | 73.2% | CN¥2.68 Billion | CN¥3.67 Billion | CN¥984.97 Million | ▼ -11.6 pp |
| 2022 | 84.7% | CN¥2.48 Billion | CN¥2.93 Billion | CN¥447.45 Million | ▲ +5.5 pp |
| 2021 | 79.2% | CN¥2.32 Billion | CN¥2.92 Billion | CN¥607.10 Million | ▲ +27.7 pp |
| 2020 | 51.5% | CN¥339.54 Million | CN¥658.75 Million | CN¥319.20 Million | ▼ -22.1 pp |
| 2019 | 73.6% | CN¥278.74 Million | CN¥378.63 Million | CN¥99.89 Million | — |